Rapamycin Exacerbates Staphylococcus aureus Pneumonia by Inhibiting mTOR-RPS6 in Macrophages

References

• Eng CP, Sehgal SN, Vézina C. Activity of rapamycin (AY-22,989) against transplanted tumors. J Antibiot. 1984;37(10):1231–1237. doi:10.7164/antibiotics.37.1231
   PubMed Web of Science ®Google Scholar
• Rasigade JP, Dumitrescu O, Lina G. New epidemiology of Staphylococcus aureus infections. Clin Microbiol Infect. 2014;20(7):587–588. doi:10.1111/1469-0691.12718
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362–386. doi:10.1128/CMR.05022-11
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–532. doi:10.1056/NEJM199808203390806
   PubMed Web of Science ®Google Scholar
• von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344(1):11–16. doi:10.1056/NEJM200101043440102
   PubMed Web of Science ®Google Scholar
• Li M, Yu J, Guo G, Shen H. Interactions between macrophages and biofilm during Staphylococcus aureus-associated implant infection: difficulties and solutions. J Innate Immun. 2023. doi:10.1159/000530385
   Google Scholar
• Nguyen M-T, Hu Z, Mohammad M, et al. Bacterial lipoproteins shift cellular metabolism to glycolysis in macrophages causing bone erosion. Microbiol Spectr. 2023;11:e0429322. doi:10.1128/spectrum.04293-22
   PubMed Web of Science ®Google Scholar
• Nguyen MT, Götz F. Lipoproteins of gram-positive bacteria: key players in the immune response and virulence. Microbiol Mol Biol Rev. 2016;80(3):891–903. doi:10.1128/MMBR.00028-16
   PubMed Web of Science ®Google Scholar
• Martel RR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol. 1977;55(1):48–51. doi:10.1139/y77-007
   PubMed Web of Science ®Google Scholar
• Andrassy J, Graeb C, Rentsch M, Jauch K-W, Guba M. mTOR inhibition and its effect on cancer in transplantation. Transplantation. 2005;80(1 Suppl):S171–S174. doi:10.1097/01.tp.0000186912.23630.85
   PubMed Web of Science ®Google Scholar
• Schnitzbauer AA, Filmann N, Adam R, et al. mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors. Ann Surg. 2020;272(5):855–862. doi:10.1097/SLA.0000000000004280
   PubMed Web of Science ®Google Scholar
• Verna EC, Patel YA, Aggarwal A, et al. Liver transplantation for hepatocellular carcinoma: management after the transplant. Am J Transplant. 2020;20(2):333–347. doi:10.1111/ajt.15697
   PubMed Web of Science ®Google Scholar
• de Fijter JW. Cancer and mTOR inhibitors in transplant recipients. Transplantation. 2017;101(1):45–55. doi:10.1097/TP.0000000000001447
   PubMed Web of Science ®Google Scholar
• Champion L, Stern M, Israël-Biet D, et al. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med. 2006;144(7):505–509. doi:10.7326/0003-4819-144-7-200604040-00009
   PubMed Web of Science ®Google Scholar
• Pham P-T-T, Pham P-CT, Danovitch GM, et al. Sirolimus-associated pulmonary toxicity. Transplantation. 2004;77(8):1215–1220. doi:10.1097/01.TP.0000118413.92211.B6
   PubMed Web of Science ®Google Scholar
• Buron F, Malvezzi P, Villar E, et al. Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study. PLoS One. 2013;8(1):e53078. doi:10.1371/journal.pone.0053078
   PubMed Web of Science ®Google Scholar
• Gudiol C, Sabé N, Carratalà J. Is hospital-acquired pneumonia different in transplant recipients? Clin Microbiol Infect. 2019;25(10):1186–1194. doi:10.1016/j.cmi.2019.04.003
   PubMed Web of Science ®Google Scholar
• Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I, et al. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant. 2011;25(6):E629–E638. doi:10.1111/j.1399-0012.2011.01495.x
   PubMed Web of Science ®Google Scholar
• Hoyo I, Linares L, Cervera C, et al. Epidemiology of pneumonia in kidney transplantation. Transplant Proc. 2010;42(8):2938–2940. doi:10.1016/j.transproceed.2010.07.082
   PubMed Web of Science ®Google Scholar
• Kreitmann L, Gaudet A, Nseir S. Ventilator-associated pneumonia in immunosuppressed patients. Antibiotics. 2023;12:2 doi:10.3390/antibiotics12020413.
   Google Scholar
• Hara K, Maruki Y, Long X, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002;110(2):177–189. doi:10.1016/S0092-8674(02)00833-4
   PubMed Web of Science ®Google Scholar
• Kim D-H, Sarbassov DD, Ali SM, et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Molecular Cell. 2003;11(4):895–904. doi:10.1016/S1097-2765(03)00114-X
   PubMed Web of Science ®Google Scholar
• Jacinto E, Loewith R, Schmidt A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biology. 2004;6(11):1122–1128. doi:10.1038/ncb1183
   PubMed Web of Science ®Google Scholar
• Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960–976. doi:10.1016/j.cell.2017.02.004
   PubMed Web of Science ®Google Scholar
• Kim H, Banerjee N, Barnes RC, et al. Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo. Mol Carcinog. 2017;56(1):197–207. doi:10.1002/mc.22484
   PubMed Web of Science ®Google Scholar
• Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265–277. doi:10.1023/A:1008942828960
   PubMed Web of Science ®Google Scholar
• Risson V, Mazelin L, Roceri M, et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol. 2009;187(6):859–874. doi:10.1083/jcb.200903131
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. doi:10.1038/nprot.2008.73
   PubMed Web of Science ®Google Scholar
• Aylett CHS, Sauer E, Imseng S, et al. Architecture of human mTOR complex 1. Science. 2016;351(6268):48–52. doi:10.1126/science.aaa3870
   PubMed Web of Science ®Google Scholar
• Zhang N, Zhao H. Enriching screening libraries with bioactive fragment space. Bioorg Med Chem Lett. 2016;26(15):3594–3597. doi:10.1016/j.bmcl.2016.06.013
   PubMed Web of Science ®Google Scholar
• De Filippo K, Henderson RB, Laschinger M, Hogg N. Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. J Immunol. 2008;180(6):4308–4315. doi:10.4049/jimmunol.180.6.4308
   PubMed Web of Science ®Google Scholar
• Kraig E, Linehan LA, Liang H, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: immunological, physical performance, and cognitive effects. Exp Gerontol. 2018;105:53–69. doi:10.1016/j.exger.2017.12.026
   PubMed Web of Science ®Google Scholar
• Rana JS, Sheikh J. Serum sickness-like reactions after placement of sirolimus-eluting stents. Ann Allergy Asthma Immunol. 2007;98(2):201–202. doi:10.1016/S1081-1206(10)60699-0
   PubMed Web of Science ®Google Scholar
• Gomez-Fernandez C, Garden BC, Wu S, Feldman DR, Lacouture ME. The risk of skin rash and stomatitis with the mammalian target of rapamycin inhibitor temsirolimus: a systematic review of the literature and meta-analysis. Eur J Cancer. 2012;48(3):340–346. doi:10.1016/j.ejca.2011.11.028
   PubMed Web of Science ®Google Scholar
• Molinari M, Al-Saif F, Ryan EA, et al. Sirolimus-induced ulceration of the small bowel in islet transplant recipients: report of two cases. Am J Transplant. 2005;5(11):2799–2804. doi:10.1111/j.1600-6143.2005.01082.x
   PubMed Web of Science ®Google Scholar
• Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol. 2012;30:39–68. doi:10.1146/annurev-immunol-020711-075024
   PubMed Web of Science ®Google Scholar
• Nakajima T, Lin K-W, Li J, et al. T cells and lung injury. Impact of rapamycin. Am J Respir Cell Mol Biol. 2014;51(2):294–299. doi:10.1165/rcmb.2013-0171OC
   PubMed Web of Science ®Google Scholar
• Hinojosa CA, Mgbemena V, Van Roekel S, et al. Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp Gerontol. 2012;47(12):958–965. doi:10.1016/j.exger.2012.08.013
   PubMed Web of Science ®Google Scholar
• Bösken B, Hepner-Schefczyk M, Vonderhagen S, Dudda M, Flohé SB. An inverse relationship between c-Kit/CD117 and mTOR confers NK cell dysregulation late after severe injury. Front Immunol. 2020;11:1200. doi:10.3389/fimmu.2020.01200
   PubMed Web of Science ®Google Scholar
• Vieira ÉLM, Martins FMA, Bellozi PMQ, et al. PI3K, mTOR and GSK3 modulate cytokines’ production in peripheral leukocyte in temporal lobe epilepsy. Neurosci Lett. 2021;756:135948. doi:10.1016/j.neulet.2021.135948
   PubMed Web of Science ®Google Scholar
• Huang T, Cui K, Song X, et al. MTOR involved in bacterial elimination against Trueperella pyogenes infection based on mice model by transcriptome and biochemical analysis. Vet Microbiol. 2019;235:199–208. doi:10.1016/j.vetmic.2019.06.021
   PubMed Web of Science ®Google Scholar
• Lv Y, Fang L, Ding P, Liu R. PI3K/Akt-Beclin1 signaling pathway positively regulates phagocytosis and negatively mediates NF-κB-dependent inflammation in Staphylococcus aureus-infected macrophages. Biochem Biophys Res Commun. 2019;510(2):284–289. doi:10.1016/j.bbrc.2019.01.091
   PubMed Web of Science ®Google Scholar
• Cai J, Li J, Zhou Y, et al. Staphylococcus aureus facilitates its survival in bovine macrophages by blocking autophagic flux. J Cell Mol Med. 2020;24(6):3460–3468. doi:10.1111/jcmm.15027
   PubMed Web of Science ®Google Scholar
• Mulcahy ME, O’Brien EC, O’Keeffe KM, Vozza EG, Leddy N, McLoughlin RM. Manipulation of autophagy and apoptosis facilitates intracellular survival of staphylococcus aureus in human neutrophils. Front Immunol. 2020;11:565545. doi:10.3389/fimmu.2020.565545
   PubMed Web of Science ®Google Scholar
• Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445–455. doi:10.1038/nature12034
   PubMed Web of Science ®Google Scholar
• Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL, Eissa NT. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med. 2009;15(3):267–276. doi:10.1038/nm.1928
   PubMed Web of Science ®Google Scholar
• Fabri M, Realegeno SE, Jo E-K, Modlin RL. Role of autophagy in the host response to microbial infection and potential for therapy. Curr Opin Immunol. 2011;23(1):65–70. doi:10.1016/j.coi.2010.10.010
   PubMed Web of Science ®Google Scholar